Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Contraception
|
May 21, 2013
The creeping Pearl: Why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills?
James Trussell, David Portman
American Journal of Obstetrics and Gynecology
|
July 4, 2006
Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial
F D Anderson, William Gibbons, David Portman
Maturitas
|
January 14, 2014
Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women
James Simon, David Portman, R Garn Mabey, et al.
Contraception
|
February 14, 2006
Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol
Freedolph D Anderson, William Gibbons, David Portman
Journal of the American Pharmacists Association : Japha
|
September 18, 2023
Pharmacist-driven deprescribing initiative in primary care
Emily Rea, David Portman, Kara Ioannou, et al.
Journal of the American Pharmacists Association : Japha
|
August 11, 2024
Reprint of: Pharmacist-driven deprescribing initiative in primary care
Emily Rea, David Portman, Kara Ioannou, et al.
Advances in Therapy
|
September 24, 2021
Variability in Contraceptive Clinical Trial Design and the Challenges in Making Comparisons Across Trials
David Portman, David L Eisenberg, Patty Cason, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
January 15, 2020
Ospemifene: A Novel Oral Therapy for Vulvovaginal Atrophy of Menopause
Robert L Reid, Denise Black, Christine Derzko, et al.
Menopause (New York, N.Y.)
|
October 24, 2013
Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause
JoAnn V Pinkerton, Risa Kagan, David Portman, et al.
The Journal of Sexual Medicine
|
March 6, 2018
Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study
James A Simon, Leonard Derogatis, David Portman, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Contraception
|
May 21, 2013
The creeping Pearl: Why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills?
James Trussell, David Portman
American Journal of Obstetrics and Gynecology
|
July 4, 2006
Long-term safety of an extended-cycle oral contraceptive (Seasonale): a 2-year multicenter open-label extension trial
F D Anderson, William Gibbons, David Portman
Maturitas
|
January 14, 2014
Long-term safety of ospemifene (52-week extension) in the treatment of vulvar and vaginal atrophy in hysterectomized postmenopausal women
James Simon, David Portman, R Garn Mabey, et al.
Contraception
|
February 14, 2006
Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol
Freedolph D Anderson, William Gibbons, David Portman
Journal of the American Pharmacists Association : Japha
|
September 18, 2023
Pharmacist-driven deprescribing initiative in primary care
Emily Rea, David Portman, Kara Ioannou, et al.
Journal of the American Pharmacists Association : Japha
|
August 11, 2024
Reprint of: Pharmacist-driven deprescribing initiative in primary care
Emily Rea, David Portman, Kara Ioannou, et al.
Advances in Therapy
|
September 24, 2021
Variability in Contraceptive Clinical Trial Design and the Challenges in Making Comparisons Across Trials
David Portman, David L Eisenberg, Patty Cason, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
January 15, 2020
Ospemifene: A Novel Oral Therapy for Vulvovaginal Atrophy of Menopause
Robert L Reid, Denise Black, Christine Derzko, et al.
Menopause (New York, N.Y.)
|
October 24, 2013
Phase 3 randomized controlled study of gastroretentive gabapentin for the treatment of moderate-to-severe hot flashes in menopause
JoAnn V Pinkerton, Risa Kagan, David Portman, et al.
The Journal of Sexual Medicine
|
March 6, 2018
Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study
James A Simon, Leonard Derogatis, David Portman, et al.
Page
of 3